Rate constants obtained by NMR spectroscopy.
Catalyst: [Au(IPr)X]a | k NMR = k1 + k2 | k 1 (dm3 mol−1 min−1) | k 2 (dm3 mol−1 min−1) | k 11 (dm3 mol−1 min−1) | k 22 (dm3 mol−1 min−1) | |
---|---|---|---|---|---|---|
X | BU | |||||
OTfa | — | 11.8 ± 1.5 | 3.2 ± 1.0 | 8.7 ± 0.6 | 1.6 ± 0.8 | 65 ± 49 |
OTfa | iPr-BU*H2SO4 | 26.5 ± 1.6 | 7.5 ± 1.7 | 18.9 ± 3.5 | 4.7 ± 3.1 | 846 ± 759 |
ClO4a | — | 11.2 ± 2.2 | 3.1 ± 1.0 | 8.0 ± 1.1 | 1.5 ± 0.6 | 92 ± 77 |
ClO4a | iPr-BU*H2SO4a | 24.5 ± 3.4 | 6.2 ± 1.9 | 18.2 ± 1.4 | 3.1 ± 0.8 | 189 ± 99 |
PF6a | — | 10.9 ± 1.5 | 2.8 ± 0.7 | 8.0 ± 0.7 | 1.2 ± 0.4 | 100 ± 85 |
PF6a | iPr-BU*H2SO4a | 22.1 ± 0.6 | 5.7 ± 1.0 | 16.5 ± 1.5 | 3.6 ± 1.0 | 571 ± 515 |
BF4a | — | 7.6 ± 1.4 | 2.2 ± 0.6 | 4.1 ± 0.6 | 0.1 ± 0.1 | 1.8 ± 0.1 |
BF4a | iPr-BU*H2SO4a | 24.8 ± 2.9 | 7.3 ± 1.4 | 17.2 ± 1.2 | 3.0 ± 0.9 | 59 ± 2 |
SbF6a | — | 12.0 ± 2.8 | 3.1 ± 1.0 | 8.8 ± 1.8 | 1.1 ± 0.1 | 100 ± 81 |
SbF6a | iPr-BU*H2SO4a | 28.8 ± 0.7 | 7.2 ± 0.6 | 21.6 ± 0.9 | 2.7 ± 0.2 | 105 ± 38 |
OTfb | — | 5.1 ± 0.1 | 1.5 ± 0.2 | 3.6 ± 0.3 | 0.6 ± 0.6 | 485 ± 240 |
OTfb | Bn-BUb | 4.6 ± 0.8 | 1.3 ± 0.1 | 3.3 ± 0.8 | 0.6 ± 0.6 | 405 ± 231 |
ClO4b | — | 6.4 ± 1.6 | 1.6 ± 0.1 | 4.7 ± 1.4 | 0.9 ± 0.9 | 578 ± 531 |
ClO4 | Bn-BUb | 5.2 ± 1.3 | 1.3 ± 0.1 | 3.9 ± 1.1 | 0.7 ± 0.7 | 403 ± 307 |
PF6b | — | 5.0 ± 0.6 | 1.6 ± 0.4 | 3.5 ± 0.2 | 1.9 ± 0.1 | 1654 ± 1335 |
PF6 | Bn-BUb | 4.0 ± 0.5 | 1.2 ± 0.1 | 2.8 ± 0.5 | 0.6 ± 0.6 | 796 ± 630 |
BF4b | — | 1.8 ± 0.8 | 1.0 ± 0.3 | 0.8 ± 0.5 | 0.1 ± 0.1 | 791 ± 761 |
BF4 | Bn-BUb | 1.7 ± 0.2 | 0.9 ± 0.2 | 0.9 ± 0.1 | 0.1 ± 0.1 | 197 ± 132 |
SbF6b | — | 4.6 ± 0.1 | 1.4 ± 0.2 | 3.2 ± 0.1 | 1.5 ± 0.1 | 779 ± 452 |
SbF6 | Bn-BUb | 3.6 ± 0.2 | 1.2 ± 0.1 | 2.5 ± 0.2 | 0.6 ± 0.6 | 759 ± 567 |
Cl | Bn-BUb,c | No reaction |
CD3OD : CD2Cl2 (1 : 0.08): 1.25 mol% [Au(IPr)X] with or without 1.25 mol% iPr-BU*H2SO4.
In CD3OD : CD2Cl2 (1 : 2.4): 1.25 mol% [Au(IPr)X] with or without 1.25 mol% Bn-BU.
The solution of Au(IPr)Cl and Bn-BU was mixed for 24 hours.